An apparatus is provided for receiving an indication of a temperature measurement made at a site on a body, the first measurement being of a first type; receiving an indication of an electrical measurement of one or more electrical characteristics made at the site where the temperature measurement was made; determining, based at least in part on the measurement of the one or more electrical characteristics, the site on the body where the temperature measurement was made; associating the measured temperature with the determined site. A method and a computer program product are also provided.

A method and system for lesion formation assessment in tissue that has undergone an ablation procedure. In one embodiment, a method of assessing lesion formation comprises: recording a baseline impedance measurement from an area of tissue with a medical device; ablating the area of tissue with the medical device; recording a post-treatment impedance measurement from the area of tissue with the medical device; identifying at least one amplitude characteristic of the baseline impedance measurement and identifying at least one amplitude characteristic of the post-treatment impedance measurement; comparing the at least one amplitude characteristic of the baseline impedance measurement and the at least one amplitude characteristic of the post-treatment impedance measurement; generating an indication of efficacy based on the comparison, the indication of efficacy being one of sufficient lesion formation and insufficient lesion formation; and re-ablating the area of tissue if the indication of efficacy is insufficient lesion formation.

A method and system for lesion formation assessment in tissue that has undergone an ablation procedure. In one embodiment, a method of assessing lesion formation comprises: recording a baseline impedance measurement from an area of tissue with a medical device; ablating the area of tissue with the medical device; recording a post-treatment impedance measurement from the area of tissue with the medical device; identifying at least one amplitude characteristic of the baseline impedance measurement and identifying at least one amplitude characteristic of the post-treatment impedance measurement; comparing the at least one amplitude characteristic of the baseline impedance measurement and the at least one amplitude characteristic of the post-treatment impedance measurement; generating an indication of efficacy based on the comparison, the indication of efficacy being one of sufficient lesion formation and insufficient lesion formation; and re-ablating the area of tissue if the indication of efficacy is insufficient lesion formation.

In some cases, a wound dressing comprises a substantially flexible substrate with a first, wound-facing side supporting a plurality of electronic components and a second side opposite the first side, wherein the substrate comprises a plurality of perforations formed though the substrate and wherein the plurality of perforations comprise walls on the exterior surface of the plurality of perforations, a first substantially stretchable coating applied to the first side of the substrate, and a second substantially stretchable coating applied to second side of the substrate, wherein the walls of the plurality of perforations are at least partially coated with at least one of the coatings.

In some cases, a wound dressing comprises a substantially flexible substrate with a first, wound-facing side supporting a plurality of electronic components and a second side opposite the first side, wherein the substrate comprises a plurality of perforations formed though the substrate and wherein the plurality of perforations comprise walls on the exterior surface of the plurality of perforations, a first substantially stretchable coating applied to the first side of the substrate, and a second substantially stretchable coating applied to second side of the substrate, wherein the walls of the plurality of perforations are at least partially coated with at least one of the coatings.

The disclosure relates to new methods for calibrating or adjusting a bioimpedance measuring device. Furthermore, the present disclosure relates to a medical set or system, a medical measuring standard, a method for testing a bioimpedance measuring device, and a bioimpedance measuring device.

The disclosure relates to new methods for calibrating or adjusting a bioimpedance measuring device. Furthermore, the present disclosure relates to a medical set or system, a medical measuring standard, a method for testing a bioimpedance measuring device, and a bioimpedance measuring device.

A sensor measurement device includes: an impedance analyzer to determine an impedance of a sample; a first antenna configured to generate electromagnetic radiation having a first wavelength; an impedance-matching device, positioned in a radiation path between the first antenna and the sample, to receive the electromagnetic radiation from the first antenna and transmit electromagnetic radiation of the first wavelength into the sample, the impedance-matching device comprising a metasurface including: a substrate having a thickness no greater than the first wavelength of the electromagnetic radiation; and a plurality of elements supported by the substrate, wherein: the plurality of elements are spaced apart from one another across the substrate, each element has a first dimension no greater than the first wavelength of the electromagnetic radiation, and at least two elements of the plurality of elements differ in one or more of shape or size; and a second antenna configured to receive the electromagnetic radiation from the sample.

A sensor measurement device includes: an impedance analyzer to determine an impedance of a sample; a first antenna configured to generate electromagnetic radiation having a first wavelength; an impedance-matching device, positioned in a radiation path between the first antenna and the sample, to receive the electromagnetic radiation from the first antenna and transmit electromagnetic radiation of the first wavelength into the sample, the impedance-matching device comprising a metasurface including: a substrate having a thickness no greater than the first wavelength of the electromagnetic radiation; and a plurality of elements supported by the substrate, wherein: the plurality of elements are spaced apart from one another across the substrate, each element has a first dimension no greater than the first wavelength of the electromagnetic radiation, and at least two elements of the plurality of elements differ in one or more of shape or size; and a second antenna configured to receive the electromagnetic radiation from the sample.

A patient monitoring device configured to monitor cardiac activity and sleep stage information of a patient is provided. The device includes a plurality of electrodes to acquire electrocardiogram (ECG) signals from the patient, at least one motion sensor configured to generate a motion signal based upon movement of the patient, and at least one processor. The processor is configured derive motion parameters from the motion signal, derive ECG parameters from the ECG signals, determine whether the patient is in an immobilized sleep stage or a non-immobilized sleep stage based upon the motion parameters and the ECG parameters, adjust one or more cardiac arrhythmia detection parameters such that the device operates in a first monitoring and treatment mode when the patient is in an immobilized sleep stage, and monitor the patient for the cardiac arrhythmia using the first monitoring and treatment mode.